Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.Gastroenterology. 2013; 145: 554-565
- Association of MDR1 gene polymorphism (G2677T) with imatinib response in Egyptian chronic myeloid leukemia patients.Hematology. 2013; ([Epub ahead of print])
- Molecular mechanisms of tumor resistance to PI3K-mTOR targeted cancer therapy.Chin J Cancer. 2013; 32: 376-379
- Furthering the design and the discovery of small molecule ATP-competitive mTOR inhibitors as an effective cancer treatment.Expert Opin Drug Discov. 2013; 8: 991-1012
Rai G, Vyjayanti VN, Dorjsuren D, et al. Small molecule inhibitors of the human apurinic/apyrimidinic endonuclease 1 (APE1). 2010.
- Comprehensive molecular oncogenomic profiling and miRNA analysis of prostate cancer.Am J Transl Res. 2013; 5: 200-211
- Evolving concept of cancer stem cells: role of micro-RNAs and their implications in tumor aggressiveness.J Carcinogene Mutagene. 2011; : 005https://doi.org/10.4172/2157-2518.S1-005
- Recent updates on the role of microRNAs in prostate cancer.J Hematol Oncol. 2012; 5: 9
- MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.Cancer Lett. 2013; 337: 226-236
- MicroRNA-219-2-3p functions as a tumor suppressor in gastric cancer and is regulated by DNA methylation.PLoS One. 2013; 8: e60369
- Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer.Diagn Pathol. 2013; 8: 69
- MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer.Br J Cancer. 2012; 107: 1354-1360
- Restoration of E-cadherin expression in pancreatic ductal adenocarcinoma treated with microRNA-101.Surgery. 2012; 152: 704-711
- Garcinol regulates EMT and Wnt signaling pathways in vitro and in vivo, leading to anticancer activity against breast cancer cells.Mol Cancer Ther. 2012; 11: 2193-2201
- Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM.PLoS One. 2012; 7: e33729
- Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.Cancer Res. 2011; 71: 3400-3409
- Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells.PLoS One. 2010; 5: e12445
- MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma.J Neurooncol. 2012; 109: 239-244
- microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.Oncol Rep. 2013; 30: 320-326
- Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC.Int J Mol Sci. 2013; 14: 10332-10342
- Dumbbell probe-mediated cascade isothermal amplification: a novel strategy for label-free detection of microRNAs and its application to real sample assay.Anal Chim Acta. 2013; 760: 69-74
- Detection of miRNAs with a nanopore single-molecule counter.Expert Rev Mol Diagn. 2012; 12: 573-584
- mirExplorer: detecting microRNAs from genome and next generation sequencing data using the AdaBoost method with transition probability matrix and combined features.RNA Biol. 2011; 8: 922-934
- MicroRNA expression analysis using the Illumina microRNA-Seq Platform.Methods Mol Biol. 2012; 822: 183-188
- Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2.Proc Natl Acad Sci U S A. 2013; 110: 8573-8578
- New molecular insights into osteosarcoma targeted therapy.Curr Opin Oncol. 2013; 25: 398-406
- Chemically modified synthetic microRNA-205 inhibits the growth of melanoma cells in vitro and in vivo.Mol Ther. 2013; 21: 1204-1211
- Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET.PLoS One. 2013; 8: e61054
- Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer.Am J Transl Res. 2010; 3: 28-47
- Inactivation of Ink4a/Arf leads to deregulated expression of miRNAs in K-Ras transgenic mouse model of pancreatic cancer.J Cell Physiol. 2012; 227: 3373-3380
- Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF.Cancer Res. 2010; 70: 3606-3617
- Characterization of microRNA expression profiles in normal human tissues.BMC Genomics. 2007; 8: 166
- miRBase: microRNA sequences and annotation.Curr Protoc Bioinformatics. 2010; 29 (12.9.1–12.9.10)
- Blood-based miRNAs as noninvasive diagnostic and surrogative biomarkers in colorectal cancer.Expert Rev Mol Diagn. 2013; 13: 141-145
- MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas.J Neurooncol. 2013; 111: 71-81
- Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer.J Cancer Res Clin Oncol. 2013; 139: 223-229
- Targeting miR-21 for the therapy of pancreatic cancer.Mol Ther. 2013; 21: 986-994
- Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.Eur J Cancer Prev. 2013; ([Epub ahead of print])
- miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN.Toxicology. 2013; 306: 162-168
- Circulating miR-155 expression in plasma: a potential biomarker for early diagnosis of esophageal cancer in humans.J Toxicol Environ Health A. 2012; 75: 1154-1162
- High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer.Eur J Cancer. 2013; 49: 604-615
- LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas.Blood. 2012; 120: 1678-1686
- Circulating microRNAs in serum of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas.Pancreas. 2012; 41: 1013-1018
- Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells.Cancer Lett. 2012; 319: 173-181
- Differential processing of let-7a precursors influences RRM2 expression and chemosensitivity in pancreatic cancer: role of LIN-28 and SET oncoprotein.PLoS One. 2013; 8: e53436
- The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer.Mol Cancer Res. 2013; 11: 240-250
- A mathematical model for microRNA in lung cancer.PLoS One. 2013; 8: e53663
- Current status and implications of microRNAs in ovarian cancer diagnosis and therapy.J Ovarian Res. 2012; 5: 44
- let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non–small–cell lung cancer.PLoS One. 2012; 7: e45577
- Clinical significance and the correlation of expression between Let-7 and K-ras in non-small cell lung cancer.Oncol Lett. 2010; 1: 1045-1047
- Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas.Virchows Arch. 2011; 458: 313-322
- Silencing of microRNAs in vivo with 'antagomirs'.Nature. 2005; 438: 685-689
- Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissues.PLoS One. 2012; 7: e45105
- Network modeling of CDF treated pancreatic cancer cells reveals a novel c-myc-p73 dependent apoptotic mechanism.Am J Transl Res. 2011; 3: 374-382
- Genome-wide profiling identified a set of miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells.PLoS One. 2012; 7: e36248
Article info
Publication history
Published online: October 11, 2013
Footnotes
The authors have nothing to disclose.
Identification
Copyright
© 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
